Pure Global
NCT05451030

Effect of Remote Ischemic Preconditioning on Cerebral Circulation Time in Patients With Severe Carotid Artery Stenosis (RIP-CCT)

The Effect of Remote Ischemic Preconditioning on Cerebral Circulation Time in Patients With Severe Carotid Artery Stenosis (RIP-CCT): A Prospective, Randomized Controlled, Blind Outcome Evaluation, Multi-center Study
General Hospital of Shenyang Military Region·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Carotid Artery Stenosis
Drug/Device/Intervention
remote ischemic preconditioning
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
General Hospital of Shenyang Military Region
Location
Shenyang, China
Timeline & enrollment
Phase
N/A
Start date
Jun 28, 2022
End date
Jun 28, 2023
Enrollment
122 participants
Primary outcome

Changes in cerebral circulation time

Summary

Cerebral circulation time in patients with severe carotid artery stenosis was found to be
 associated with hyperperfusion syndrome. Remote ischemic preconditioning can change the
 ability of cerebral autoregulation. The prospective, randomized controlled, blind outcome
 evaluation, multi-center study aimed to investigate the effect of remote ischemic
 preconditioning on cerebral circulation time in patients with severe carotid artery stenosis.

ICD-10 classifications
Occlusion and stenosis of carotid arteryCarotid artery syndrome (hemispheric)Injury of carotid arteryAneurysm and dissection of carotid arteryOcclusion and stenosis of vertebral artery
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05451030
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05451030 through Pure Global AI's free database. This phase not specified trial is sponsored by General Hospital of Shenyang Military Region and is currently Recruiting. The study focuses on Carotid Artery Stenosis. Target enrollment is 122 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.